Press release
mRNA Vaccines & Therapeutics Market: Competitive Dynamics & Global Outlook 2020-2025
Get Full PDF Sample Copy of Report: (Including Full TOC, List of Tables & Figures, Chart) https://www.globalinforesearch.com/Global-mRNA-Vaccines-&-Therapeutics_p495642.html
As part of competitive analysis, the research study includes exhaustive company profiling of leading players of the global mRNA Vaccines & Therapeutics market. All of the segments studied in the report are analyzed based on different factors such as market share, revenue, and CAGR. The analysts have also thoroughly analyzed different regions such as North America, Europe, and Asia Pacific on the basis of production, revenue, and sales in the global mRNA Vaccines & Therapeutics market. The researchers used advanced primary and secondary research methodologies and tools for preparing this report on the global mRNA Vaccines & Therapeutics market.
Key Players Mentioned in the Global mRNA Vaccines & Therapeutics Market Research Report:
Moderna Therapeutics
eTheRNA
BioNTech
CureVac
In-Cell-Art
Translate Bio
Tiba Biotechnology
Argos Therapeutics
Sangamo Therapeutics
Ethris
Global mRNA Vaccines & Therapeutics Market Segmentation by Product:
Infectious Disease Vaccines
Cancer Vaccines
Global mRNA Vaccines & Therapeutics Market Segmentation by Application:
Infectious Disease
Cancer
The global mRNA Vaccines & Therapeutics market is segmented on the basis of type of product, application, and region. The analysts authoring the report provide a meticulous evaluation of all of the segments included in the report. The segments are studied keeping in view their market share, revenue, market growth rate, and other vital factors. The segmentation study equips interested parties to identify high-growth portions of the global mRNA Vaccines & Therapeutics market and understand how the leading segments could grow during the forecast period.
This is one of the most important sections of the research study as it provides deep insights into the growth of the mRNA Vaccines & Therapeutics market at both country and regional level. The researchers estimate market growth in different regions and countries by both value and volume. They accurately calculate the revenue, price, CAGR, consumption, sales, and other factors related to the regional markets studied here.
Report Objectives
To carefully analyze and estimate the size of the global mRNA Vaccines & Therapeuticsmarket
To clearly segment the global mRNA Vaccines & Therapeuticsmarket and estimate the market size of the segments
To provide details about key strategies adopted by leading players of the global mRNA Vaccines & Therapeuticsmarket
To help readers understand current and future market scenarios
To provide information about latest trends of the global mRNA Vaccines & Therapeuticsmarket and its key segments
To assess the contribution of each region or country to the global mRNA Vaccines & Therapeuticsmarket
To provide information on important drivers, restraints, and opportunities of the global mRNA Vaccines & Therapeuticsmarket
To accurately calculate the market shares of key segments, regions, and companies in the global mRNA Vaccines & Therapeuticsmarket
Request for customization in Report: https://www.globalinforesearch.com/Global-mRNA-Vaccines-&-Therapeutics_p495642.html
Table of Content
1 Market Overview
1.1 mRNA Vaccines & Therapeutics Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global mRNA Vaccines & Therapeutics Revenue by Type: 2015 VS 2019 VS 2025
1.2.2 Infectious Disease Vaccines
1.2.3 Cancer Vaccines
1.3 Market Analysis by Application
1.3.1 Overview: Global mRNA Vaccines & Therapeutics Revenue by Application: 2015 VS 2019 VS 2025
1.3.2 Infectious Disease
1.3.3 Cancer
1.4 Overview of Global mRNA Vaccines & Therapeutics Market
1.4.1 Global mRNA Vaccines & Therapeutics Market Status and Outlook (2015-2025)
1.4.2 North America (United States, Canada and Mexico)
1.4.3 Europe (Germany, France, United Kingdom, Russia and Italy)
1.4.4 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
1.4.5 South America, Middle East & Africa
1.5 Market Dynamics
1.5.1 Market Opportunities
1.5.2 Market Risk
1.5.3 Market Driving Force
2 Manufacturers Profiles
2.1 Moderna Therapeutics
2.1.1 Moderna Therapeutics Details
2.1.2 Moderna Therapeutics Major Business
2.1.3 Moderna Therapeutics SWOT Analysis
2.1.4 Moderna Therapeutics Product and Services
2.1.5 Moderna Therapeutics mRNA Vaccines & Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.2 eTheRNA
2.2.1 eTheRNA Details
2.2.2 eTheRNA Major Business
2.2.3 eTheRNA SWOT Analysis
2.2.4 eTheRNA Product and Services
2.2.5 eTheRNA mRNA Vaccines & Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.3 BioNTech
2.3.1 BioNTech Details
2.3.2 BioNTech Major Business
2.3.3 BioNTech SWOT Analysis
2.3.4 BioNTech Product and Services
2.3.5 BioNTech mRNA Vaccines & Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.4 CureVac
2.4.1 CureVac Details
2.4.2 CureVac Major Business
2.4.3 CureVac SWOT Analysis
2.4.4 CureVac Product and Services
2.4.5 CureVac mRNA Vaccines & Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.5 In-Cell-Art
2.5.1 In-Cell-Art Details
2.5.2 In-Cell-Art Major Business
2.5.3 In-Cell-Art SWOT Analysis
2.5.4 In-Cell-Art Product and Services
2.5.5 In-Cell-Art mRNA Vaccines & Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.6 Translate Bio
2.6.1 Translate Bio Details
2.6.2 Translate Bio Major Business
2.6.3 Translate Bio Product and Services
2.6.4 Translate Bio mRNA Vaccines & Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.7 Tiba Biotechnology
2.7.1 Tiba Biotechnology Details
2.7.2 Tiba Biotechnology Major Business
2.7.3 Tiba Biotechnology Product and Services
2.7.4 Tiba Biotechnology mRNA Vaccines & Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.8 Argos Therapeutics
2.8.1 Argos Therapeutics Details
2.8.2 Argos Therapeutics Major Business
2.8.3 Argos Therapeutics Product and Services
2.8.4 Argos Therapeutics mRNA Vaccines & Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.9 Sangamo Therapeutics
2.9.1 Sangamo Therapeutics Details
2.9.2 Sangamo Therapeutics Major Business
2.9.3 Sangamo Therapeutics Product and Services
2.9.4 Sangamo Therapeutics mRNA Vaccines & Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.10 Ethris
2.10.1 Ethris Details
2.10.2 Ethris Major Business
2.10.3 Ethris Product and Services
2.10.4 Ethris mRNA Vaccines & Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
3 Sales, Revenue and Market Share by Manufacturer
3.1 Global mRNA Vaccines & Therapeutics Sales and Market Share by Manufacturer (2018-2019)
3.2 Global mRNA Vaccines & Therapeutics Revenue and Market Share by Manufacturer (2018-2019)
3.3 Market Concentration Rate
3.3.1 Top 3 mRNA Vaccines & Therapeutics Manufacturer Market Share in 2019
3.3.2 Top 6 mRNA Vaccines & Therapeutics Manufacturer Market Share in 2019
3.4 Market Competition Trend
4 Global Market Analysis by Regions
4.1 Global mRNA Vaccines & Therapeutics Sales, Revenue and Market Share by Regions
4.1.1 Global mRNA Vaccines & Therapeutics Sales and Market Share by Regions (2015-2020)
4.1.2 Global mRNA Vaccines & Therapeutics Revenue and Market Share by Regions (2015-2020)
4.2 North America mRNA Vaccines & Therapeutics Sales and Growth Rate (2015-2020)
4.3 Europe mRNA Vaccines & Therapeutics Sales and Growth Rate (2015-2020)
4.4 Asia-Pacific mRNA Vaccines & Therapeutics Sales and Growth Rate (2015-2020)
4.5 South America mRNA Vaccines & Therapeutics Sales and Growth Rate (2015-2020)
4.6 Middle East and Africa mRNA Vaccines & Therapeutics Sales and Growth Rate (2015-2020)
5 North America by Country
5.1 North America mRNA Vaccines & Therapeutics Sales, Revenue and Market Share by Country
5.1.1 North America mRNA Vaccines & Therapeutics Sales and Market Share by Country (2015-2020)
5.1.2 North America mRNA Vaccines & Therapeutics Revenue and Market Share by Country (2015-2020)
5.2 United States mRNA Vaccines & Therapeutics Sales and Growth Rate (2015-2020)
5.3 Canada mRNA Vaccines & Therapeutics Sales and Growth Rate (2015-2020)
5.4 Mexico mRNA Vaccines & Therapeutics Sales and Growth Rate (2015-2020)
6 Europe by Country
6.1 Europe mRNA Vaccines & Therapeutics Sales, Revenue and Market Share by Country
6.1.1 Europe mRNA Vaccines & Therapeutics Sales and Market Share by Country (2015-2020)
6.1.2 Europe mRNA Vaccines & Therapeutics Revenue and Market Share by Country (2015-2020)
6.2 Germany mRNA Vaccines & Therapeutics Sales and Growth Rate (2015-2020)
6.3 UK mRNA Vaccines & Therapeutics Sales and Growth Rate (2015-2020)
6.4 France mRNA Vaccines & Therapeutics Sales and Growth Rate (2015-2020)
6.5 Russia mRNA Vaccines & Therapeutics Sales and Growth Rate (2015-2020)
6.6 Italy mRNA Vaccines & Therapeutics Sales and Growth Rate (2015-2020)
7 Asia-Pacific by Regions
7.1 Asia-Pacific mRNA Vaccines & Therapeutics Sales, Revenue and Market Share by Regions
7.1.1 Asia-Pacific mRNA Vaccines & Therapeutics Sales and Market Share by Regions (2015-2020)
7.1.2 Asia-Pacific mRNA Vaccines & Therapeutics Revenue and Market Share by Regions (2015-2020)
7.2 China mRNA Vaccines & Therapeutics Sales and Growth Rate (2015-2020)
7.3 Japan mRNA Vaccines & Therapeutics Sales and Growth Rate (2015-2020)
7.4 Korea mRNA Vaccines & Therapeutics Sales and Growth Rate (2015-2020)
7.5 India mRNA Vaccines & Therapeutics Sales and Growth Rate (2015-2020)
7.6 Southeast Asia mRNA Vaccines & Therapeutics Sales and Growth Rate (2015-2020)
7.7 Australia mRNA Vaccines & Therapeutics Sales and Growth Rate (2015-2020)
8 South America by Country
8.1 South America mRNA Vaccines & Therapeutics Sales, Revenue and Market Share by Country
8.1.1 South America mRNA Vaccines & Therapeutics Sales and Market Share by Country (2015-2020)
8.1.2 South America mRNA Vaccines & Therapeutics Revenue and Market Share by Country (2015-2020)
8.2 Brazil mRNA Vaccines & Therapeutics Sales and Growth Rate (2015-2020)
8.3 Argentina mRNA Vaccines & Therapeutics Sales and Growth Rate (2015-2020)
9 Middle East & Africa by Countries
9.1 Middle East & Africa mRNA Vaccines & Therapeutics Sales, Revenue and Market Share by Country
9.1.1 Middle East & Africa mRNA Vaccines & Therapeutics Sales and Market Share by Country (2015-2020)
9.1.2 Middle East & Africa mRNA Vaccines & Therapeutics Revenue and Market Share by Country (2015-2020)
9.2 Saudi Arabia mRNA Vaccines & Therapeutics Sales and Growth Rate (2015-2020)
9.3 Turkey mRNA Vaccines & Therapeutics Sales and Growth Rate (2015-2020)
9.4 Egypt mRNA Vaccines & Therapeutics Sales and Growth Rate (2015-2020)
9.5 South Africa mRNA Vaccines & Therapeutics Sales and Growth Rate (2015-2020)
10 Market Segment by Type
10.1 Global mRNA Vaccines & Therapeutics Sales and Market Share by Type (2015-2020)
10.2 Global mRNA Vaccines & Therapeutics Revenue and Market Share by Type (2015-2020)
10.3 Global mRNA Vaccines & Therapeutics Price by Type (2015-2020)
11 Global mRNA Vaccines & Therapeutics Market Segment by Application
11.1 Global mRNA Vaccines & Therapeutics Sales Market Share by Application (2015-2020)
11.2 Global mRNA Vaccines & Therapeutics Revenue Market Share by Application (2015-2020)
11.3 Global mRNA Vaccines & Therapeutics Price by Application (2015-2020)
12 Market Forecast
12.1 Global mRNA Vaccines & Therapeutics Sales, Revenue and Growth Rate (2021-2025)
12.2 mRNA Vaccines & Therapeutics Market Forecast by Regions (2021-2025)
12.2.1 North America mRNA Vaccines & Therapeutics Market Forecast (2021-2025)
12.2.2 Europe mRNA Vaccines & Therapeutics Market Forecast (2021-2025)
12.2.3 Asia-Pacific mRNA Vaccines & Therapeutics Market Forecast (2021-2025)
12.2.4 South America mRNA Vaccines & Therapeutics Market Forecast (2021-2025)
12.2.5 Middle East & Africa mRNA Vaccines & Therapeutics Market Forecast (2021-2025)
12.3 mRNA Vaccines & Therapeutics Market Forecast by Type (2021-2025)
12.3.1 Global mRNA Vaccines & Therapeutics Sales Forecast by Type (2021-2025)
12.3.2 Global mRNA Vaccines & Therapeutics Market Share Forecast by Type (2021-2025)
12.4 mRNA Vaccines & Therapeutics Market Forecast by Application (2021-2025)
12.4.1 Global mRNA Vaccines & Therapeutics Sales Forecast by Application (2021-2025)
12.4.2 Global mRNA Vaccines & Therapeutics Market Share Forecast by Application (2021-2025)
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.2 Distributors, Traders and Dealers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Data Source
15.3 Disclaimer
15.4 About US
About Us:
GlobaI Info Research（GIR） is a report publisher, a customer, interest-based suppliers. Is in the best interests of our clients, they determine our every move. At the same time, we have great respect for the views of customers. With the improvement of the quality of our research, we develop custom interdisciplinary and comprehensive solution. For further development, we will do better and better. GlobalInfoResearch will with excellent professional knowledge and experience to carry out all aspects of our business. At the same time, we will thoroughly look for information, to give a more comprehensive development.
Contact US
Global Info Research
E-mail: report@globalinforesearch.com
Tel: +86-13660489451 00852-58197708(HK)
Add:FLAT/RM A 9/F SILVERCORP INTERNATIONAL TOWER 707-713 NATHAN ROAD MONGKOK KL HONG KONG
Website: http://www.globalinforesearch.com
Contact US
Global Info Research
E-mail: report@globalinforesearch.com
Tel: +86-13660489451 00852-58197708(HK)
Add:FLAT/RM A 9/F SILVERCORP INTERNATIONAL TOWER 707-713 NATHAN ROAD MONGKOK KL HONG KONG
Website: http://www.globalinforesearch.com
GlobaI Info Research（GIR） is a report publisher, a customer, interest-based suppliers. Is in the best interests of our clients, they determine our every move. At the same time, we have great respect for the views of customers. With the improvement of the quality of our research, we develop custom interdisciplinary and comprehensive solution. For further development, we will do better and better. GlobalInfoResearch will with excellent professional knowledge and experience to carry out all aspects of our business. At the same time, we will thoroughly look for information, to give a more comprehensive development.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release mRNA Vaccines & Therapeutics Market: Competitive Dynamics & Global Outlook 2020-2025 here
News-ID: 2140223 • Views: …
More Releases from GLOBAL INFO RESEARCH
Global Long Chain Dicarboxylic Acid Market Growth Forecast Report 2025-2031
On Sep 5, the latest report "Global Long Chain Dicarboxylic Acid Market 2025 by Manufacturers, Regions, Types and Applications, Forecast to 2031" from Global Info Research provides a detailed and comprehensive analysis of the global Long Chain Dicarboxylic Acid market. The report provides both quantitative and qualitative analysis by manufacturers, regions and countries, types and applications. As the market is constantly changing, this report explores market competition, supply and demand…
Low Density Polyethylene (LDPE) Latest Market Analysis Report 2025
On Sep 5, 2025, Global Info Research released a research report titled "Global Low Density Polyethylene (LDPE) Market 2025 by Manufacturers, Regions, Type and Application, Forecast to 2031". This report provides detailed data analysis of the Low Density Polyethylene (LDPE) market from 2020 to 2031. Including the market size and development trends of Low Density Polyethylene (LDPE) Market, it analyzes market size indicators such as sales, sales volume,…
Lubricant Viscosity Grade Improvers Market Share, Revenue, Price, Growth Rate Ra …
Global Info Research's report offers key insights into the recent developments in the global Lubricant Viscosity Grade Improvers market that would help strategic decisions. It also provides a complete analysis of the market size, share, and potential growth prospects. Additionally, an overview of recent major trends, technological advancements, and innovations within the market are also included. Our report further provides readers with comprehensive insights and actionable analysis on the…
Global Mining Flotation Chemicals Market Competitor Analysis Report 2025
On Sep 5, 2025, Global Info Research released a research report titled "Global Mining Flotation Chemicals Market 2025 by Manufacturers, Regions, Type and Application, Forecast to 2031". This report provides detailed data analysis of the Mining Flotation Chemicals market from 2020 to 2031. Including the market size and development trends of Mining Flotation Chemicals Market, it analyzes market size indicators such as sales, sales volume, average price and…
More Releases for Therapeutics
Adrenomyeloneuropathy Market: Epidemiology, Therapies, Companies, DelveInsight | …
Adrenomyeloneuropathy emerging therapies are expected to boost the Adrenomyeloneuropathy Market in the upcoming years.
DelveInsight has launched a new report on "Adrenomyeloneuropathy - Market Insights, Epidemiology, and Market Forecast-2034" that delivers an in-depth understanding of the Adrenomyeloneuropathy, historical and forecasted epidemiology as well as the Adrenomyeloneuropathy market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan.
Discover about the Adrenomyeloneuropathy market report @ https://www.delveinsight.com/report-store/adrenomyeloneuropathy-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=kpr
Some of the…
Pompe Disease Market: Epidemiology, Therapies, Companies, DelveInsight | Genzyme …
Pompe Disease emerging therapies, such as MYOZYME (alglucosidase alfa), LUMIZYME, AAV2/8-LSPhGAA, Avalglucosidase alfa, and others, are expected to boost the Pompe Disease Market in the upcoming years.
DelveInsight has launched a new report on "Pompe Disease - Market Insights, Epidemiology, and Market Forecast-2034" that delivers an in-depth understanding of the Pompe Disease, historical and forecasted epidemiology as well as the Pompe Disease market trends in the United States, EU5 (Germany, Spain,…
Dark Genome Therapeutics Market Deep Research Report with Forecast to 2032 | myN …
The qualitative latest Research report (2025-2032) on the Dark Genome Therapeutics Market by Coherent Market Insights Provides a deep dive into key market trends, drivers, challenges, and the competitive landscape. It analyzes market size, revenue, production, and CAGR using validated methodologies to ensure precision. The report highlights tech innovation, pricing trends, consumer behavior, and investment potential - empowering businesses to make informed, strategic moves.
Request a Sample Copy: https://www.coherentmarketresearch.com/samplepages/133611
Focused on growth…
Hodgkin's lymphoma Therapeutics Market Size Report 2032 | Affimed Therapeutics, …
DelveInsight's "Hodgkin's Lymphoma Market Insights, Epidemiology, and Market Forecast - 2032" report delivers an in-depth understanding of the Hodgkin's Lymphoma, historical and forecasted epidemiology as well as the Hodgkin's Lymphoma market trends in the United States, EU4 (Germany, Spain, Italy, and France) and the United kingdom and Japan.
Discover Key Insights into the Hodgkin's lymphoma Market with DelveInsight's In-Depth Report @ Hodgkin's lymphoma Market Size- https://www.delveinsight.com/sample-request/hodgkins-lymphoma-hl-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=ypr
Key Takeaways from the Hodgkin's…
CRISPR Therapies Pipeline 2024 | Intellia Therapeutics, CRISPR therapeutics, Rep …
DelveInsight's, "CRISPR Therapies Pipeline Insight 2024" report provides comprehensive insights about 25+ CRISPR Therapies Companies and 30+ pipeline drugs in CRISPR Therapies pipeline landscape. It covers the CRISPR Therapies pipeline drug profiles, including clinical and nonclinical stage products. It also covers the CRISPR Therapies therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive CRISPR Therapies pipeline products in this space.
Key Takeaways from…
Digital Therapeutics Market, Digital Therapeutics Market Size, Digital Therapeut …
The global digital therapeutics market is expected to reach US$ 8,941.1 Mn by 2025 from US$ 1,993.2 Mn in 2017. The market is estimated to grow with a CAGR of 20.8% during the forecast period from 2018 to 2025.
North America is the largest geographic market and it is expected to be the largest revenue generator during the forecast period, whereas the market is expected to witness growth at a significant…
